AzTrials
AzTrials

Concussion, BrainNCT06263179

Feasibility of Aerobic Exercise for Recovery From Work-related Concussion

A study testing Target Heartrate Aerobic Exercise in people with Concussion, Brain, run by State University of New York at Buffalo at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is a lot of research on how to treat people with sport-related concussion. There has not been a lot of research on the treatment of injured workers with concussion. An exercise program has been developed for people with sport-related concussion. Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Concussion, Brain
What is being tested?
Target Heartrate Aerobic Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
1 Jul 2024to 30 Apr 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged 18-40
  • Received a concussion at work and are engaged with the workers compensation program
  • Within 3 weeks of concussive injury

Who cannot join

  • 3-point or less difference between current and pre-injury symptoms as measured by the Post-Concussion Symptom Inventory (PCSI)
  • Moderate or severe TBI
  • Injury involving loss of consciousness for >30 minutes or post-traumatic amnesia > 24 hours
  • Pre-existing conditions or presence of polytrauma that prevent participation in active testing and/or rehabilitation
  • History of more than 3 diagnosed concussions
  • Active substance abuse/dependence
Show all 9Show fewer
  • Report of injury mechanism occurring due to physical assault
  • Unwillingness to perform intervention
  • Limited English proficiency.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UBMD Orthopaedics and Sports Medicine

    Williamsville, New York, 14221

Other trials in United States

About this study

There is a lot of research on how to treat people with sport-related concussion. There has not been a lot of research on the treatment of injured workers with concussion. An exercise program has been developed for people with sport-related concussion. It is suspected that this program may be helpful for injured workers with concussion too. This study will test the effect of this exercise in injured workers with concussion.

Read the detailed description

Participants who are diagnosed with a concussion and agree to participant in the study will complete a demographics form and other relevant questionnaires. They will then perform a graded exertion test (the Buffalo Concussion Treadmill Test [BCTT]) at the clinic, this takes approximately 15 minutes. Participants will then be prescribed the individualized THRAE based on the results from the BCTT and will be sent home with a commercial heart rate monitor. Participants will perform exercises at home on their free time 4-5 days per week. Participants will return to the clinic weekly to be re-examined by the study physician and obtain a new heart rate prescription for the first six weeks until clinical recovery or the intervention period ends (6-weeks).

Being tested
Target Heartrate Aerobic Exercise
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Target Heartrate Aerobic ExerciseBehavioural

    Exercise program

Study groups in NCT06263179
Study groupRoleWhat they receive
Target Heartrate Aerobic Exercise (THRAE)ExperimentalParticipants will be asked to complete the Buffalo Concussion Treadmill Test (BCTT), a safe graded exercise test that is used to identify concussion-related exertion intolerance. Participants will wear a heart rate (HR) monitor for the collection of continuous HR data. The test is stopped when a participant's symptoms increase subjectively by an intensity of 3 points or more from the pre-exercise value on a scale from 0-10, or they report being physically exhausted. Their HR at the time of test termination constitutes the HR threshold (HRt). An individualized THRAE program will be prescribed based on 80% of the HRt on the BCTT. Participants will be given a Polar HR monitor to wear while performing their THRAE prescription, which will be performed at home for 20 minutes, 4-5 days per week, for 6 weeks or until medically cleared from their concussion.
Receives: Behavioral: Target Heartrate Aerobic Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) Program as Measured by Counting the Number and Duration of Exercise Sessions Completed.

    Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by a subjective report at each weekly meeting with the study's research assistant of exercise sessions performed. Participants were considered adherent if they complete 66% or more of their prescribed exercise sessions

    Measured: Up to 6 weeks

  2. Objective Adherence to Target Heartrate Aerobic Exercise (THRAE)

    Objective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by counting exercise sessions completed across participants using Polar app. Adherence was calculated by counting the number of exercise sessions logged within the system for all participants and dividing that value by the number days all subjects were eligible to exercise during their time in the study.

    Measured: Up to 6 weeks.

Secondary outcomes (7)
  1. Change in Post-concussive Symptom Burden as Measured by the Post-Concussion Symptom Scale

    The Post-Concussion Symptom Scale (PCSS) is a validated 22-item self-report symptom questionnaire. Scores range from 0-132 with greater scores indicating increased symptom burden.

    Measured: Baseline and final visit (6 weeks) or the visit the participant was deemed recovered, whichever occurred first.

  2. Change in Patient Health Questionnaire-9 (PHQ-9)

    The Patient Health Questionnaire-9 (PHQ-9) is used for rating the severity of depression among participants. Scores range from 0-27. Higher scores indicate increased severity of depression. To calculate change in Patient Health Questionnaire-9 (PHQ-9) scores, the mean final PHQ-9 score for all participants was subtracted from the mean initial score for all participants.

    Measured: Baseline, up to week 6

  3. Change in Generalized Anxiety Disorder-7 (GAD-7)

    The Generalized Anxiety Disorder-7 (GAD-7) is used to measure the severity of anxiety among participants. Scores range from 0-21. Higher scores indicate increased severity of anxiety.

    Measured: Baseline, up to week 6

  4. Number of Participants With Positive Primary Care Post Traumatic Stress Disorder (PTSD) Screen for DSM-5 (PC-PTSD-5)

    This is a brief screening measure designed to identify individuals with probable post-traumatic stress disorder (PTSD). The measure begins with a trauma-exposure screening item; if no trauma exposure is endorsed, the score is 0. If trauma exposure is endorsed, 5 yes/no symptom items are completed. The total score is calculated by adding the number of "yes" responses yielding a range from 0 to 5. Lower scores indicate lower likelihood of PTSD; higher scores indicate greater likelihood of PTSD. Greater than 2 "yes" responses was considered a positive screen.

    Measured: Baseline

  5. Change in Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10)

    The PROMIS Global Health-10 is a 10-item patient-reported measure of general health-related quality of life, including physical, mental, and social health. Raw scores are converted to a standardized T-score. T-scores have a mean of 50 and standard deviation of 10 in the reference population. Higher scores represent a better outcome, indicating better global physical or mental health; lower scores represent a worse outcome. Change in PROMIS-10 was calculated by subtracting the average score for all participants at Visit 1 from the average score for all participants at the final visit.

    Measured: Baseline, up to week 6

  6. Work Climate Questionnaire - 6-Item Version

    The Work Climate Questionnaire - 6-Item Version is used for assessing participants' perceptions regarding the degree of autonomy supportiveness of their work managers or employers. Scores range of 6-42. Higher scores indicate a greater degree of perceived autonomy supportiveness.

    Measured: Baseline

  7. Change in Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS)

    This is a self-report measure assessing satisfaction and frustration of three basic psychological needs: autonomy, competence, and relatedness. Twenty-four items are rated from 1 to 5. Possible scores range from 24-120. Higher scores indicate greater psychological need satisfaction and less frustration. Change in this measure was calculated by subtracting the average score for all participants obtained at the final visit from the average score for all participants obtained at the initial study visit.

    Measured: Baseline, up to week 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2024
  2. Study start1 Jul 2024
  3. Primary completion30 Apr 2025
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Target Heartrate Aerobic Exercise
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06263179
Sponsor's protocol ID
STUDY00007706
Other IDs
UL1TR001412
Status last verified
Oct 2026
First submitted
29 Jan 2024
Last updated
28 Oct 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sharma B, Nowrouzi-Kia B, Mollayeva T, Kontos P, Grigorovich A, Liss G, Gibson B, Mantis S, Lewko J, Colantonio A. Work-related traumatic brain injury: A brief report on workers perspective on job and health and safety training, supervision, and injury preventability. Work. 2019;62(2):319-325. doi: 10.3233/WOR-192866.

    PubMed 30829642
  • Leddy JJ, Haider MN, Ellis MJ, Mannix R, Darling SR, Freitas MS, Suffoletto HN, Leiter J, Cordingley DM, Willer B. Early Subthreshold Aerobic Exercise for Sport-Related Concussion: A Randomized Clinical Trial. JAMA Pediatr. 2019 Apr 1;173(4):319-325. doi: 10.1001/jamapediatrics.2018.4397.

    PubMed 30715132
  • Leddy JJ, Master CL, Mannix R, Wiebe DJ, Grady MF, Meehan WP, Storey EP, Vernau BT, Brown NJ, Hunt D, Mohammed F, Mallon A, Rownd K, Arbogast KB, Cunningham A, Haider MN, Mayer AR, Willer BS. Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial. Lancet Child Adolesc Health. 2021 Nov;5(11):792-799. doi: 10.1016/S2352-4642(21)00267-4. Epub 2021 Oct 1.

    PubMed 34600629
  • de Koning ME, Scheenen ME, van der Horn HJ, Timmerman ME, Hageman G, Roks G, Spikman JM, van der Naalt J. Prediction of work resumption and sustainability up to 1 year after mild traumatic brain injury. Neurology. 2017 Oct 31;89(18):1908-1914. doi: 10.1212/WNL.0000000000004604. Epub 2017 Oct 6.

    PubMed 28986414
  • Kristman VL, Cote P, Van Eerd D, Vidmar M, Rezai M, Hogg-Johnson S, Wennberg RA, Cassidy JD. Prevalence of lost-time claims for mild traumatic brain injury in the working population: improving estimates using workers compensation databases. Brain Inj. 2008 Jan;22(1):51-9. doi: 10.1080/02699050701849991.

    PubMed 18183509
  • Smith CK, Wuellner S, Marcum J. Racial and ethnic disparities in workers' compensation claims rates. PLoS One. 2023 Jan 17;18(1):e0280307. doi: 10.1371/journal.pone.0280307. eCollection 2023.

    PubMed 36649295
  • McPherson JI, Miecznikowski JC, Chizuk H, Sparks P, Leddy JJ, Haider MN, Stavisky CJ. Feasibility trial protocol assessing the use of aerobic exercise to promote recovery from work-related concussion. PLoS One. 2025 Jun 12;20(6):e0325701. doi: 10.1371/journal.pone.0325701. eCollection 2025.

    PubMed 40504846

Questions about this trial

What is this clinical trial studying?

A study testing Target Heartrate Aerobic Exercise in people with Concussion, Brain, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Oct 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) Program as Measured by Counting the Number and Duration of Exercise Sessions Completed. (time frame: Up to 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06263179, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in